Drug intelligence / Profile preview

Ustilago maydis

Development stage: Preclinical
Administration: Subcutaneous, Intradermal, Sublingual

Overview

Ustilago maydis is a biotrophic plant-pathogenic fungus that causes corn smut disease in maize, leading to biomass and yield loss. It is extensively studied as a model organism to understand fungal pathogenicity, host-pathogen interactions, and metabolic processes. Research indicates its ability to exploit host signaling pathways, such as lateral root regulators and jasmonic acid signaling, to induce gall formation. Furthermore, U. maydis is utilized in biotechnological applications for the production of valuable chemicals like itaconic acid and mannosylerythritol lipids (MELs).

Other names: U. maydis

Targets

CTS (Cathepsin family)

Beyond the preview

Go deeper on Ustilago maydis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ustilago maydis.

Explore the full profile